Mustafa Kaplan

No Difference Between Latiglutenase and Placebo in Reducing Villous Atrophy or Improving Symptoms in Patients With Symptomatic Celiac Disease

Joseph A. Murray, Ciarán P. Kelly, Peter H.R. Green et al. · Gastroenterology · 2016 · 131 citations · Full text

Difference Between Latiglutenase, Villous Atrophy, Clinical Presentation +3

Determination of thiol/disulphide homeostasis in type 1 diabetes mellitus and the factors associated with thiol oxidation

İhsan Ateş, Mustafa Kaplan, Mahmut Yüksel et al. · Endocrine · 2015 · 120 citations

Metabolic Syndrome, Type 1, Diabetes Management +11

Platelet-to-Lymphocyte Ratio and Neutrophil-to-Lymphocyte Ratio Predict Mucosal Disease Severity in Ulcerative Colitis

Muhammet Yener AKPINAR, Mustafa Kaplan, İhsan Ateş et al. · Journal of Medical Biochemistry · 2017 · 97 citations · Full text

Value of Dynamic Contrast-Enhanced MRI and Correlation with Tumor Angiogenesis in Bladder Cancer

Nermin Tunçbilek, Mustafa Kaplan, Şemsi Altaner et al. · American Journal of Roentgenology · 2009 · 76 citations

Urology, Engineering, Microvessel Density +14

Serum, urinary and stone zinc, iron, magnesium and copper levels in idiopathic calcium oxalate stone patients

İrfan H. Atakan, Mustafa Kaplan, Gülay Şeren et al. · International Urology and Nephrology · 2007 · 74 citations

Electrolyte Disorder, Urology, Health Sciences +8